CVS investors have the opportunity to lead CVS Health Corporation’s securities fraud lawsuit with the Schall law firm

Los Angeles, California–(Newsfile Corp. – August 16, 2024) – Schall Law Firm, a national shareholder rights law firm, reminds investors of a class action lawsuit against CVS Health Corporation (“CVS” or “the Company”) (NYSE: CVS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between May 3, 2023 and April 30, 2024, inclusive (the “Class Period”), are encouraged to contact the Firm before September 10, 2024.